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J PStroke, a devastating complication of sickle cell anemia (SCA), can cause irreversible brain injury
with physical and cognitive deﬁcits. Transcranial Doppler ultrasonography (TCD) is a non-invasive
tool for identifying children with SCA at highest risk of stroke. National guidelines recommend that
TCD screening begin at age 2 years, yet there is research to suggest less than half of young children
undergo screening. The purpose of this project was to use quality improvement methods to improve
the proportion of patients aged 24–27 months who successfully completed their initial TCD from
25% to 75% by December 31, 2013. Quality improvement methods (e.g., process mapping, simpliﬁed
failure mode effect analysis, and plan–do–study–act cycles) were used to develop and test processes
for identifying eligible patients, scheduling TCDs, preparing children and families for the ﬁrst TCD,
and monitoring outcomes (i.e., TCD protocol). Progress was tracked using a report of eligible
patients and a chart showing the age in months for the ﬁrst successful TCD (population metric). As
of December 2013, 100% of eligible patients successfully completed their initial TCD screen; this
improvement was maintained for the next 20 months. In November 2014, a Welch’s one-way
ANOVA was conducted. Results showed a statistically signiﬁcant difference between the average age
of ﬁrst TCD for eligible patients born in 2009 and eligible patients born during the intervention
period (2010–2013; F[1,11.712]¼16.03, p¼0.002). Use of quality improvement methods to implement
a TCD protocol was associated with improved TCD screening rates in young children with SCA.
(Am J Prev Med 2016;51(1S1):S10–S16) & 2016 American Journal of Preventive Medicine. Published by
Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).IntroductionStroke, a devastating complication of sickle cellanemia (SCA), can cause irreversible brain injurywith physical and cognitive deﬁcits.1 Without
primary prevention, 10% of children with SCA will expe-
rience an overt ischemic stroke by age 20 years, with the
highest incidence at age 2–5 years.2–4 Given the irreversible
brain damage that a single stroke can cause, prevention is
essential5 and ongoing efforts are needed to improve the
availability and implementation of stroke prevention pro-
grams. Transcranial Doppler ultrasonography (TCD) is ancinnati Children’s Hospital Medical Center, Cincinnati,
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an open access article under the CC BY-NCnon-invasive tool that can identify children with SCA at
highest risk of overt stroke.6 Use of chronic blood trans-
fusion therapy in these children signiﬁcantly reduces the
ﬁrst stroke incidence.5–8
National SCA guidelines recommend that TCD screen-
ing should begin at age 2 years, continuing annually until
age 16 years.9–11 Magnetic resonance imaging/angio-
graphic abnormalities have been reported in children as
young as 7–48 months, reinforcing the need to begin
screening at this age. In 2011, the authors reviewed all
cases of new overt stroke in SCA patients during the
preceding 10 years at Cincinnati Children’s Hospital
Medical Center (CCHMC) and found that the frequency
of stroke had signiﬁcantly decreased after the implemen-
tation of routine TCD screening in 2005. However, the last
two overt strokes occurred in children who were younger
than 3 years and had not yet had an initial TCD
examination, although one had been scheduled. At the
time, the average age at initial TCD was 33.2 months, and
only 25% of patients had successfully completed a TCD by
age 27 months. This is not surprising because the mereJournal of Preventive Medicine. Published by Elsevier Inc. This is
-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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guarantee implementation.12 An analysis of the failures
(children aged 24–36 months who had not received an
initial TCD screen) revealed variability in processes related
to identifying eligible patients, educating parents, schedul-
ing TCDs, tracking TCD completion, and acting upon
results. Moreover, the clinical team did not systematically
prepare children and families for the procedure, but only
asked families whether they thought their child could
complete the TCD examination.
A multidisciplinary quality improvement (QI) team
convened to develop a reliable process for TCD screening
consistent with national recommendations. The primary
aim was to increase the proportion of eligible children
with SCA (hemoglobin [Hb]SS or sickle-β0-thalassemia)
aged 24–27 months who successfully completed their
initial TCD from 25% (baseline) to 75% by December 31,
2013. This paper describes the QI methods used to
develop and implement a process for obtaining initial
TCDs within a busy pediatric sickle cell clinic.
Methods
Setting
A non-proﬁt, 587-bed children’s hospital, CCHMC serves South-
ern Ohio, Northern Kentucky, and Southeastern Indiana. The
Cincinnati Comprehensive Sickle Cell clinic at CCHMC is the
regional coordinating center for the hemoglobinopathy newborn
screening program and cares for all children with sickle cell disease
from birth to age 21 years (N¼280). Most patients (475%) reside
within a 15-mile radius; therefore, the center provides acute and
chronic care for these patients and maintains an electronic medical
record (EMR) patient registry.Study Sample
Participants were included in analyses if they met the following
criteria: (1) SCA (HbSS or HbSβ0-thalassemia) diagnosis docu-
mented via ICD-9 Code in the EMR (Epic Systems) registry; and
(2) born between January 1, 2009 (aged 5 years 4 months), and
December 31, 2011 (aged 1 year 5 months). Older children were
not targeted because data indicated that the majority of children
agedZ5 years 5 months had successfully completed initial TCDs.Procedures
The TCD exams at CCHMC are conducted by certiﬁed radiologic
technologists following the Stroke Prevention Trial in Sickle Cell
Anemia (STOP) protocol with modiﬁcations for an imaging TCD
technique.13,14 All exams were performed in the Radiology depart-
ment. To address the challenges of conducting full TCD exams in
younger patients, a multidisciplinary core QI team consisting of two
physicians, two psychologists, four nurse practitioners, three SCA
nurse care managers, a QI consultant, and a data analyst began
meeting weekly with regular input from radiologic technologists,
Child Life specialists, social workers, school interventionists, designJuly 2016and technology students, and consultants. The team’s ﬁrst step was
to develop a key driver diagram that described the project aim,
measures, and drivers for change. Next, a process map or pictorial
representation of all of the steps in the process of scheduling and
following up on initial TCDswas developed.15 This was followed by a
simpliﬁed failure mode and effect analysis (SFMEA), where each step
in the process was identiﬁed as well as potential failures and then the
failures were evaluated and ranked.16,17 The ﬁnal step was to develop
potential strategies to address high-ranking failures. The SFMEA
revealed failures related to provider awareness and education, family
education and preparation, and scheduling and follow-up. From
February 2012 to December 2013, the team conducted a series of
plan–do–study–act cycles (PDSAs) to develop and test strategies to
address identiﬁed failures. PDSA cycles use a “trial-and-learning”
approach to test a strategy on a small scale.18,19 Test results then
guide the next steps (i.e., Should the strategy be adapted, adopted or
abandoned?). Once PDSA data indicated stable screening comple-
tion rates, the process for the initial TCD was ﬁnalized. Because the
purpose of this project was to improve care locally, the IRB deemed it
QI, exempted it from review, and waived written informed consent.Statistical Analysis
To monitor progress, a report listing SCA patients needing an
initial TCD and their status was used. An accompanying chart
showing the age in months for the initial TCD (population metric)
for patients born between 2009 and 2011 was developed.
To examine whether TCD screening performance differed
before and after the intervention, the average age of initial TCD
for eligible patients with SCA born in 2009 (pre-intervention
group) was compared with the average age of initial TCD for
eligible patients with SCA born in 2010–2011 (intervention
group). Because the sample size of the groups differed (pre-
intervention group had 15 patients [80% male, 100% HbSS, 73.3%
public insurance], whereas the intervention group had nine
patients [44.4% male, 100% HbSS, 77.8% public insurance]), a
Welch’s one-way ANOVA was conducted using SAS, version 9.3.
Analyses were conducted in November 2014.Results
Development and Implementation of the Process
for Initial Transcranial Doppler Ultrasonography
A review of data showed variability in scheduling initial
TCDs due to a lack of (1) provider awareness that initial
TCDs were not occurring as close to age 2 years as
possible; (2) team motivation to change the process
because of doubt that screening rates would improve;
and (3) the perception that TCDs would not be successful
in less cooperative young children. Thus, the improve-
ment work began with a series of PDSAs focused on
provider awareness, education, and motivation. Speciﬁ-
cally, educational presentations on evidence-based rec-
ommendations, baseline TCD screening rates, and the
gap in performance were tested to see if scheduling rates
would improve. The scheduling rate increased brieﬂy
and then returned to baseline, which was attributed
Crosby et al / Am J Prev Med 2016;51(1S1):S10–S16S12to education alone not being enough (i.e., families
continued to no-show and TCD completion was not
monitored). The next series of PDSAs tested interactive
meetings where providers completed a key driver dia-
gram, a process map, and the SFMEA. Following this, the
scheduling rate improved brieﬂy but this was not
maintained. The third set of PDSAs focused on demon-
strating that with proper preparation patients could
successfully undergo TCD at around age 24 months.
The team identiﬁed two potential patients aged 24–27
months, provided education during their clinic visits, and
scheduled TCDs. The successful completion of TCDs in
these patients generated provider consensus for changing
the TCD process. Figure 1 shows a timeline for the initial
TCD process.
Although providers were now hopeful that changing
the process could improve the initial TCD screening rate,
there were barriers related to family education and
preparation. Young children had difﬁculty lying still
and staying awake for the 45 to 60–minute procedure.
Hence, a series of PDSAs tested a “prep book” of pictures
and short descriptions to walk families through the TCD
exam. Testing revealed providers had difﬁculty remem-
bering to review the prep book with families in the
absence of reminders. Once these were in place, providers
(usually the nurse) reliably reviewed the prep book with
families; parents reported the prep book was useful but
requested two additional tools: (1) a video of the actual
TCD exam and (2) written materials to share with others
at home. Consequently, team members from Child LifeFigure 1. Timeline for initial transcranial Doppler ultrasonograpand Psychology developed a video of a TCD exam with a
young child, which parents reported was helpful. To
address the desire for written materials, PDSAs shifted to
developing two brochures, one to explain the rationale
for TCD screening (TCD Educational brochure) and one
to help parents prepare the child (TCD Parenting Tips).
Two brochures were developed, as parents described
having one brochure with all of the information as
overwhelming. Families suggested all of the educational
materials (prep book, video, and TCD Educational and
TCD Parenting Tips brochures) were useful, so a parent
education toolkit or bundle was created.
With the toolkit complete, PDSAs focused on imple-
mentation (i.e., how and when families should receive the
toolkit). A series of tests revealed families wanted the
toolkit mailed to them at least 2 weeks prior to the TCD
appointment and a phone call 48 hours after the mailing.
To accommodate this change in process, care managers
began systematically collecting updated contact informa-
tion from families during clinic visits. Phone calls
revealed that the majority of families’ questions were
related to preparing their child for the TCD; thus, the
team tested having the psychologist call families. The
care manager documented the parent follow-up call and
then routed it to a psychologist. Two weeks later, the
psychologist called and reviewed the toolkit information
and documented this in the EMR. Families were readily
available and engaged well in conversation with the
psychologist during the 10-minute phone call; hence,
this process change was adopted.hy (TCD) process.
www.ajpmonline.org
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during clinic visits. After several cycles, the team adopted
a process where the care manager initiated a TCD
discussion at the 18-month visit, provided a copy of the
TCD Knowing Note (plain-language educational bro-
chure designed for patients and families) to the family,
and documented the education in the EMR.
The SFMEA revealed no systematic way of identifying
eligible patients or tracking TCD scheduling or comple-
tion. The data analyst then developed an EMR report to
identify patients agedZ17 months without a completed
TCD. During pre-visit planning, the team reviewed this
list and implemented the process beginning with family
education at the 18-month visit (Figure 2 shows the ﬁnal
process). Once this part of the process was stable, the
EMR report was automated.
The team wanted TCDs scheduled on the same day as
an SCD clinic visit for timely review of results with the
family. PDSAs tested scheduling the procedure at various
times relative to child’s developmental needs (e.g., after
breakfast, after nap) and the clinic visit (before physical and
labs drawn). Results indicated the optimal time was 8:00AM
or 8:30AM, as children had eaten, were alert, and could
attend a clinic visit afterwards. PDSAs tested TCDs with
and without a Child Life specialist present and found they
were essential to the process (i.e., provided reinforcement
and distractions like movies to help children stay still).
The follow-up process became the focus of a series of
PDSAs. Care managers tested a phone script to deter-
mine the reason for missed appointments. If the TCDFigure 2. Final process for initial transcranial Doppler ultrasono
EMR, electronic medical record.
July 2016was missed because the child was ill, could not lay still, or
the family showed signs of low motivation, the care
manager repeated the TCD education provided at the 18-
month visit and mailed the TCD toolkit again. Every
effort was made to reschedule any TCDs within 1–2
months of the original appointment.
Initial Transcranial Doppler Ultrasonography
Screening Rate
As of December 2013, after the implementation of the
new process for the initial TCD, 100% of eligible patients
who needed initial TCD screening successfully received
it, and this performance was maintained for the next 20
months (n¼6) (Figure 3). Three patients after December
2013 did not receive their initial TCD on time. All TCDs
were scheduled within the appropriate timeframe but
they were unsuccessful because of one child being ill,
another’s inability to lie still, and a no-show.
By December 2013, the average age of initial TCD
decreased to 27.2 months. A Welch’s one-way ANOVA
found a statistically signiﬁcant difference between the pre-
and post-intervention groups (F[1,11.712]¼16.03, p¼0.002;
Figure 4). For eligible patients born in 2009, the average
age at initial TCD was 33.2 compared with 25.0 months
for eligible patients born between 2010 and 2011.
Discussion
Stroke is a devastating complication of SCA.1 TCD
screening has been shown to identify children withgraphy (TCD).
Figure 3. Age (in months) at initial transcranial Doppler ultrasonography (TCD) over time (completed appointments only).
Crosby et al / Am J Prev Med 2016;51(1S1):S10–S16S14SCA at highest risk of stroke.6 National guidelines
recommend screening children beginning at age 2
years9–11; however, successfully performing TCD can be
challenging in children that young. Using QI methods, a
multidisciplinary team developed and implemented aFigure 4. Distribution of age pre and post implementation of thprocess for obtaining initial TCDs for young children
with SCA in a busy outpatient clinic. Following imple-
mentation of the new process, the team exceeded its goal:
One hundred percent of eligible patients received an
initial TCD screen, and this performance was maintainede initial transcranial Doppler ultrasonography (TCD) process.
www.ajpmonline.org
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screening was signiﬁcantly different before and after the
intervention (33.2 vs 25.0 months). This ﬁnding is
consistent with other studies demonstrating that TCD
screening can be performed successfully in children
younger than age 3 years.20,21 The ﬁnal TCD process
included several effective TCD screening strategies sup-
ported in the literature (e.g., telephone support, schedul-
ing TCDs to coincide with clinic visits).22,23 However,
this study differed in important ways. A previous study
found higher rates of TCD screen adherence in patients
with private insurance.24 The current intervention
improved the initial TCD screen rate in a sample of
patients with primarily public insurance, suggesting it
may have broad clinical utility. Similar to McCarville and
colleagues,23 conducing TCDs in conjunction with a
clinic visit was effective; however, the current project
differed in that technologists conducted the TCD screens
in the Radiology department. This approach is not
without limitations such as the potential for increased
costs and resources (e.g., psychologists, Child Life
specialists) but has some advantages (e.g., comprehensive
examination, improved clinic ﬂow). The Child Life
specialist might have been obviated with the use of an
abbreviated TCD examination protocol (e.g., BabyHUG
abbreviated TCD20), but this was not possible because the
institution’s Radiology department speciﬁes that all
patients have complete examinations by a radiologic
technologist.
The QI methods were essential for increasing pro-
viders’ awareness and motivation to change their practice
around scheduling initial TCD screens. Educational
presentations on current screening rates as well as
reasons for failures and successes were not sufﬁcient.
Only when a small test of change showed TCD screens
completed with a small number of patients aged 24–27
months (i.e., two) did providers come to consensus on
trialing a change in the process.
Process mapping and conducting the SFMEA were
extremely useful. Developing the map aided the team in
examining the ﬂow and identifying barriers across the
entire process. This comprehensive, systematic approach
uncovered key drivers of the process (e.g., SCA nurse care
managers, parental need for tips to prepare their child for
the TCD) that could have been missed using a different
approach. For example, in order for the process for the
initial TCD to be implemented successfully, SCA nurse
care managers’ workﬂow and responsibilities had to be
changed. Care managers expanded their workﬂow to
include preparing TCD eligibility information for pre-
visit planning meetings, mailing TCD toolkits, calling
families to follow-up on toolkit and missed appoint-
ments, routing phone calls to the psychologist in theJuly 2016EMR, and scheduling TCDs at a speciﬁc time with the
radiologic technologist and a Child Life specialist. They
also took on the new role of updating family contact
information.
Because QI methods incorporate contextual factors
that inﬂuence a process,25 the team was able to develop a
TCD process that addressed salient patient/family bar-
riers identiﬁed as important for adherence in prior TCD
screening studies. Had patient factors not been consid-
ered in a systematic way, the team may have failed to
develop educational materials parents felt were necessary
(e.g., TCD video, TCD Parenting Tips brochure).Limitations
First, this study did not include a control or usual care
group against which to compare TCD screening rates, so
it is possible that the described changes were inﬂuenced
by other factors. However, other interventions appeared
to have little inﬂuence over TCD screening rates at the
beginning of this project (2010). Furthermore, no other
stroke prevention project or changes in transfusion
guidelines were launched from 2010 to 2012, decreasing
the likelihood that improvements were due to external
factors. Second, it is possible there were residual con-
founders to the improvement given that the team was
working on multiple clinical outcomes projects (e.g.,
home pain management plan).26 It is also possible that
clinical outcomes improved because of other factors such
as general SCD quality care initiatives. Third, the team
used all available data in comparing the average age of
initial TCD pre- and post-intervention; however, the
post-intervention period was twice as long as the pre-
intervention period because fewer patients with HbSS
were born during the post-intervention period. This may
have biased results. Last, this project took place at a single
center, included a small numbers of patients, and was
dependent upon documentation in the EMR by the SCA
nurse care manager.Conclusions
Methods for QI were an effective means to implement an
evidence-based practice guideline for young children
with SCA. The average age at initial TCD decreased
from 33.2 to 25.0 months after the new process for initial
TCDs was implemented. Although the direct causes for
improvements (e.g., parent education versus follow-up
phone call) were not examined, this study contributes to
the limited literature on QI in pediatric SCA11,26–28 and
addresses a critical gap: the implementation of a TCD
screening program for young children with SCA in a
real-world setting.
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